<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04645628</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A01969-30</org_study_id>
    <nct_id>NCT04645628</nct_id>
  </id_info>
  <brief_title>Optimization of the Acquisition Sequence to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam</brief_title>
  <acronym>AIMANT</acronym>
  <official_title>Optimization of the Acquisition Sequence to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the optimization of MRI acquisition sequences.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2020</start_date>
  <completion_date type="Anticipated">December 3, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 3, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality based on standard imaging quality criteria.</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>The image quality will be appreciated visually at least by a radiologist or a researcher.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of the Signal to Noise Ratio obtained by the optimized MRI sequence and the reference situation (standard sequence).</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Signal to Noise Ratio will be measured in arbitrary units.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the Contrast to Noise Ratio obtained by the optimized MRI sequence and the reference situation (standard sequence).</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Contrast to Noise Ratio will be measured in arbitrary units.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the acquisition time obtained with the optimized MRI sequence and the reference situation (standard sequence).</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Time acquisition will be evaluated in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of blurring and artefacts obtained by the optimized MRI sequence and the reference situation (standard sequence).</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Absence of blurring and artefacts will be assessed by at least one radiologist according to an ordinal scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of the spatial resolution obtained by the optimized MRI sequence and the reference situation (standard sequence).</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Spatial resolution will be measured in mm².</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Qualification of the MRI acquisition for a clinical study.</measure>
    <time_frame>6 months after the inclusion</time_frame>
    <description>Validation of MRI acquisition by a centralized review center.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of intra-subject reproducibility on the same MRI and on two MRIs.</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Measurement of intra-subject reproducibility on the same MRI and on two MRIs by the intra-class correlation coefficient for quantitative measurement or by the kappa coefficient for a qualitative measurement.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">720</enrollment>
  <condition>Healthy Subjects</condition>
  <condition>Patient Performing an MRI Examination</condition>
  <arm_group>
    <arm_group_label>All subjects will have an MRI examination</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI examination</intervention_name>
    <description>All subjects (healthy subjects and patients) will have an MRI examination with optimized sequences</description>
    <arm_group_label>All subjects will have an MRI examination</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for all subjects :&#xD;
&#xD;
          -  to be over 18 year-old,&#xD;
&#xD;
          -  to be able to understand the instructions given,&#xD;
&#xD;
          -  to be enrolled in a social security plan,&#xD;
&#xD;
          -  to have underwent a pre-inclusion medical examination,&#xD;
&#xD;
          -  to give a written consent.&#xD;
&#xD;
        Inclusion Criteria especially for Patients :&#xD;
&#xD;
          -  to perform a MRI examination of the head, neck, spine, thorax, abdomen, pelvis,&#xD;
             retroperitoneum, lower limbs, upper limbs or whole body during clinical follow-up&#xD;
             care.&#xD;
&#xD;
        Exclusion Criteria for all subjects :&#xD;
&#xD;
          -  any contraindication to MR examination (active medical device, ferromagnetic foreign&#xD;
             body, pregnancy, morbid obesity, claustrophobia, … ),&#xD;
&#xD;
          -  subject under a measure of legal protection.&#xD;
&#xD;
        Exclusion Criteria especially for Healthy Subjects :&#xD;
&#xD;
          -  to have a pathology in the anatomical area to be imaged&#xD;
&#xD;
          -  to be employed by the CHRU of Nancy or having the slightest link of subordination with&#xD;
             the CHRU of Nancy.&#xD;
&#xD;
        Exclusion Criteria especially for Patients :&#xD;
&#xD;
          -  to have a limited MRI examination time due to a sensitive clinical situation&#xD;
             (sedation, unstable hemodynamic state, postoperative).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Valérie LAURENT, MD, PhD</last_name>
    <phone>+33383154181</phone>
    <email>v.laurent@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela HOSSU, PhD</last_name>
    <phone>+33383155096</phone>
    <email>g.hossu@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>5400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Laurent, Md, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 16, 2020</study_first_submitted>
  <study_first_submitted_qc>November 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 27, 2020</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Valérie LAURENT</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

